ROS1 NSCLC

ROS1-positive NSCLC is a rare lung cancer subtype. Targeted therapies like ROS1 inhibitors offer promising treatment options. Discover how genetic testing can identify ROS1 rearrangements, improving patient outcomes. Consult your oncologist today to explore personalized treatment strategies for ROS1 NSCLC and enhance survival rates. Act now!

Showing all 3 results

Scroll to Top